A study to evaluate the co-relation between single nucleotide polymorphisms (SNPs) in SULT1E1 and treatment response to abiraterone acetate in patients with metastatic castration refractory prostate cancer (mCRPC)

Trial Profile

A study to evaluate the co-relation between single nucleotide polymorphisms (SNPs) in SULT1E1 and treatment response to abiraterone acetate in patients with metastatic castration refractory prostate cancer (mCRPC)

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Mar 2016

At a glance

  • Drugs Abiraterone acetate (Primary)
  • Indications Prostate cancer
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 30 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top